At the BIOPROM forum, Larisa Matveeva, Executive Director of the AIPM, and Andrey Zamyatnin, Dean of Moscow State University's Bioengineering and Bioinformatics Faculty, signed an agreement to foster collaboration. This partnership aims to equip MSU graduates with the skills needed for success in the pharmaceutical industry and to promote joint efforts in science, education, and industry.
"Moscow State University is our nation's leading university, producing highly qualified professionals for all science-intensive sectors. Pharmaceuticals are among the most technologically advanced industries, making our collaboration with pharmaceutical representatives crucial. Without understanding the industry's specific needs and features, we cannot prepare competent and in-demand specialists," says Andrey Zamyatnin.
International scientific collaboration is vital for the development of Russia's pharmaceutical industry. In today's rapidly changing technological landscape, innovation is key to success. International pharmaceutical companies continue to be reliable partners, implementing projects for technology transfer, scientific cooperation, and the development of advanced skills.
"The industry needs specialists who not only understand the development of medicines and biochemical products but are also ready to adapt to the digital transformation. Essential skills include working with big data, understanding complex business processes, and engaging in cross-functional collaboration. Modern pharmaceutical production is a unified digital ecosystem, and graduates must be prepared to function effectively within this framework," stresses Larisa Matveeva.
For insights into global scientific collaboration and the future of personnel, check out Larisa Matveeva's interview on BIOPROM Talks:
"Moscow State University is our nation's leading university, producing highly qualified professionals for all science-intensive sectors. Pharmaceuticals are among the most technologically advanced industries, making our collaboration with pharmaceutical representatives crucial. Without understanding the industry's specific needs and features, we cannot prepare competent and in-demand specialists," says Andrey Zamyatnin.
International scientific collaboration is vital for the development of Russia's pharmaceutical industry. In today's rapidly changing technological landscape, innovation is key to success. International pharmaceutical companies continue to be reliable partners, implementing projects for technology transfer, scientific cooperation, and the development of advanced skills.
"The industry needs specialists who not only understand the development of medicines and biochemical products but are also ready to adapt to the digital transformation. Essential skills include working with big data, understanding complex business processes, and engaging in cross-functional collaboration. Modern pharmaceutical production is a unified digital ecosystem, and graduates must be prepared to function effectively within this framework," stresses Larisa Matveeva.
For insights into global scientific collaboration and the future of personnel, check out Larisa Matveeva's interview on BIOPROM Talks: